Predictors and variability of drug‐eluting vs bare‐metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study

Drug‐eluting stents (DES) reduce risk of in‐stent restenosis after percutaneous coronary intervention (PCI) but require dual antiplatelet therapy (DAPT) for a longer term than bare‐metal stents (BMS). Few studies have examined clinical predictors of DES vs BMS, and variability in provider selection...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Shafiq, Ali, Gosch, Kensey, Amin, Amit P., Ting, Henry H., Spertus, John A., Salisbury, Adam C.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2017
Assuntos:
Quality and Outcomes
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805558/
https://ncbi.nlm.nih.gov/pubmed/28300284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados